Dr. Jorge A. Garcia-Young
Claim this profileSutter Solano Medical Center/Cancer Center
Studies Melanoma
Studies Cutaneous Melanoma
7 reported clinical trials
20 drugs studied
Area of expertise
1Melanoma
BRAF positive
Stage IV
Stage III
2Cutaneous Melanoma
BRAF positive
Stage IV
Stage III
Affiliated Hospitals
Clinical Trials Jorge A. Garcia-Young is currently running
Multiple Targeted Therapies
for Meningioma
This trial studies four drugs to treat patients with worsening meningioma. These drugs work by blocking enzymes that the tumor cells need to grow. The trial focuses on patients whose tumors have specific genetic mutations.
Recruiting1 award Phase 210 criteria
Nivolumab + Ipilimumab + Sargramostim
for Advanced Melanoma
This phase II/III trial studies the side effects of nivolumab and ipilimumab when given together with or without sargramostim and to see how well they work in treating patients with stage III-IV melanoma that cannot be removed by surgery (unresectable) and that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). Immunotherapy with monoclonal antibodies, such as ipilimumab and nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Colony-stimulating factors, such as sargramostim, may increase the production of white blood cells. It is not yet known whether nivolumab and ipilimumab are more effective with or without sargramostim in treating patients with melanoma.
Recruiting1 award Phase 2 & 323 criteria
More about Jorge A. Garcia-Young
Clinical Trial Related10 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Jorge A. Garcia-Young has experience with
- Nivolumab
- Ipilimumab
- Dabrafenib Mesylate
- Trametinib Dimethyl Sulfoxide
- Sargramostim
- Carboplatin
Breakdown of trials Jorge A. Garcia-Young has run
Melanoma
Cutaneous Melanoma
Breast Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jorge A. Garcia-Young specialize in?
Jorge A. Garcia-Young focuses on Melanoma and Cutaneous Melanoma. In particular, much of their work with Melanoma has involved BRAF positive patients, or patients who are Stage IV.
Is Jorge A. Garcia-Young currently recruiting for clinical trials?
Yes, Jorge A. Garcia-Young is currently recruiting for 5 clinical trials in Vallejo California. If you're interested in participating, you should apply.
Are there any treatments that Jorge A. Garcia-Young has studied deeply?
Yes, Jorge A. Garcia-Young has studied treatments such as Nivolumab, Ipilimumab, Dabrafenib Mesylate.
What is the best way to schedule an appointment with Jorge A. Garcia-Young?
Apply for one of the trials that Jorge A. Garcia-Young is conducting.
What is the office address of Jorge A. Garcia-Young?
The office of Jorge A. Garcia-Young is located at: Sutter Solano Medical Center/Cancer Center, Vallejo, California 94589 United States. This is the address for their practice at the Sutter Solano Medical Center/Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.